Extracellular matrix accumulation in immune-mediated tubulointerstitial injury.
暂无分享,去创建一个
Y. Xia | L. Feng | C. Wilson | Winson W. Tang | Yiyang Xia | W. Tang | Lili Feng | C. Wilson | L. Feng
[1] L. Feng,et al. Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. , 1993, Journal of the American Society of Nephrology : JASN.
[2] Y. Xia,et al. LPS-induced MCP-1, IL-1 beta, and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat kidney. , 1993, The American journal of physiology.
[3] L. Matrisian. The matrix‐degrading metalloproteinases , 1992, Journal of neuro-oncology.
[4] C. Alpers,et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor , 1992, The Journal of experimental medicine.
[5] M. Post,et al. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. , 1991, Kidney international.
[6] K. Suzuki,et al. Substrate specificities and activation mechanisms of matrix metalloproteinases. , 1991, Biochemical Society transactions.
[7] D. Auble,et al. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. , 1991, Biochemistry.
[8] B. Wasylyk,et al. The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.
[9] D. Skup,et al. Increased collagenase activity in metastatic cells as a result of decreased TIMP expression. , 1991, The Journal of rheumatology. Supplement.
[10] R. Medcalf,et al. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Sporn,et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.
[12] T. Curry,et al. Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries. , 1990, Endocrinology.
[13] J. Mimuro. [Type 1 plasminogen activator inhibitor]. , 1990, Rinsho byori. The Japanese journal of clinical pathology.
[14] J. McPherson,et al. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. , 1989, The Journal of clinical investigation.
[15] M. Laiho,et al. Growth factors in the regulation of pericellular proteolysis: a review. , 1989, Cancer research.
[16] A. Eisen,et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Sobel,et al. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. , 1988, The Journal of biological chemistry.
[18] W. Mckeehan,et al. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Moscatelli,et al. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells , 1987, The Journal of cell biology.
[20] J. Heath,et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.
[21] D. Swann,et al. The effect of platelet-derived growth factor on cell division and glycosaminoglycan synthesis by human skin and scar fibroblasts. , 1987, The Journal of investigative dermatology.
[22] L. Matrisian,et al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Presta,et al. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration , 1986, Molecular and cellular biology.
[24] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Massagué,et al. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.
[26] Z. Werb,et al. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.
[27] J. Quigley,et al. The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants , 1985, The Journal of cell biology.
[28] D. Loskutoff,et al. Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator. , 1985, The Journal of laboratory and clinical medicine.
[29] S. Teitelbaum,et al. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. , 1985, The Journal of clinical investigation.
[30] E. Bauer,et al. Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Hazleman,et al. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. , 1983, The Biochemical journal.
[32] A. Eisen,et al. A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. , 1979, The Journal of biological chemistry.
[33] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[34] C. Wilson,et al. Interstitial nephritis in rats immunized with heterologous tubular basement membrane. , 1974, Kidney international.
[35] L. Matrisian,et al. Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.
[36] G. González-Ávila,et al. Experimental diffuse interstitial renal fibrosis. A biochemical approach. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[37] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.